Oral estrogen treatment induces a decrease in expression of sialyl Lewis x on α1-acid glycoprotein in females and male-to-female transsexuals

Glycobiology

Volumn 6, Issue 4, 1996, Pages 407-412

  Brinkman Van Der Linden, Els C M ^a   Havenaar, Ellen C ^a   Van Ommen, Esther C R ^a   Van Kamp, Gerard J ^b   Gooren, Louis J G ^b   Van Dijk, Willem ^a,c  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NONE   (Netherlands)

Author keywords

Contraceptives oral; Estrogens; Fucosylation; Orosomucoid; Sialyl Lewis x

Indexed keywords

CONJUGATED ESTROGEN; CYPROTERONE ACETATE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; ORAL CONTRACEPTIVE AGENT; OROSOMUCOID; SIALIC ACID DERIVATIVE;

ARTICLE; FEMALE; FUCOSYLATION; GLYCOSYLATION; HUMAN; HUMAN EXPERIMENT; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SERUM; TRANSDERMAL DRUG ADMINISTRATION; TRANSSEXUALISM;

EID: 0029773383     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/6.4.407     Document Type: Article

References (42)

1. Baumann, H. and Gauldie, J. (1994) The acute phase response. Immunol. Today, 15, 74-80.
2. 1-acid glycoprotein: importance of its carbohydrate moiety. Proc. Natl. Acad. Sci. USA, 77, 6109-6113.
3. Bierhuizen, M.F.A., De Wit, M., Govers, C.A.R.L., Ferwerda, W., Koeleman, C., Pos, O. and Van Dijk, W. (1988) Glycosylation of three molecular forms of human α1-acid glycoprotein having different interactions with concanavalin A. Variations in the occurrence of di-, tri,- and tetraantenary glycans and the degree of sialylation. Eur. J. Biochem., 175, 387-394.
4. Bøg-Hansen, T.C. (1973) Crossed immunoaffinoelectrophoresis: an analytical method to predict the result of affinity chromatography Anal. Biochem., 56, 480-488.
5. 1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity. Inflammation, 14, 315-323.
6. x groups. Glycoconjugate J., 13, 27-31.
7. 1-acid glycoprotein. Br. J. Cancer, 62, 712-717.
8. Chetkowski, R.J., Meldrum, D.R., Steingold, K.A., Randle, D.R , Lu, J.K., Eggena, P., Hershman, J.M , Alkjaersig, N.K., Fletcher, A.P. and Judd, H.L. (1986) Biologic effects of transdermal estradiol. N. Engl. J. Med., 314, 1615-1620.
9. 1-acid glycoprotein. Nature, 281, 677-678.
10. 1-acid glycoprotein (orosomucoid) in human sera. J Exp. Med., 177, 657-666.
11. 1-acid glycoprotein in the serum of rheumatoid arthritis patients: a longitudinal study. J. Rheumatol., 21, 2209-2216.
12. 1H NMR spectroscopy and permethylation analysis. Biochemistry, 17, 5206-5214.
13. Fox, H.S., Bond, B.L. and Parslow, T.G. (1991) Estrogen regulates the IFN-τ promoter. J. Immunol., 146, 4362-4367
14. Hao, Y.L. and Wickerhauser, M. (1973) Development of large scale fractionation methods. IV. A simple method for the large-scale preparation of alpha 1-acid glycoprotein. Biochim. Biophys. Acta, 322, 99-108.
15. 1-acid glycoprotein in Hyperimmunoglobulinemia D and periodic fever syndrome: evidence for persistent inflammation. Clin. Immunol. Immunopathol., 76, 279-284.
16. Hu, S.-K., Mitcho, Y.L. and Rath, N C. (1988) Effect of estradiol on interleukin 1 synthesis by macrophages. J. Immunopharmacol., 10, 247-250.
17. Lawrence, J.S. (1970) Rheumatoid arthritis: nature of nurture? Ann. Rheum. Dis., 29, 357-379.
18. 1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus. Arthritis Rheum., 30, 513-518.
19. Mancini, G., Carbonara, A.O. and Heremans, J.F. (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry, 2, 235-254.
20. McCruden, A.B., and Stimson, W.H. (1991) Sex hormones and immune function. In Ader, R., Felten, D.L. and Cohen, M. (eds.), Psychoneuroimmunology Academic Press, New York, pp. 475-493.
21. Neumann, F. (1987) Pharmacology and clinical uses of cyproterone acetate. In Wakeling, A. (ed), Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action. Baillière Tindall, London, pp. 132-159.
22. 1-acid glycoprotein after induction of the acute-phase response in rats. J. Pharm. Pharmacol., 44, 447-450.
23. 1-acid glycoprotein in the detection of intercurrent infection in patients with rheumatoid arthritis. Arthritis Rheum., 32, 347-351.
24. Polderman, K.H., Stehouwer, C.D.A., Van Kamp, G.J., Dekker, G.A., Verheugt, F.W.A. and Gooren, L.J.G. (1993) Influence of sex hormones on plasma endothelin levels. Ann. Intern. Med., 118, 429-432.
25. 1-acid glycoprotein: studies with primary human hepatocyte cultures and rats. Inflammation, 13, 415-424.
26. 1-acid glycoprotein (AGP) is more effective in modulation of lymphocyte proliferation than Con A-reactive AGP serum variants. Inflammation, 14, 133-141.
27. 1-protease inhibitor in severely burned patients: relation to interleukin-6 levels. Clin. Exp. Immunol., 82, 579-582.
28. Ravn, V., Mandel, U , Svenstrup, B. and Dabelsteen, E. (1994) Blood group A/B-defined glycosyltransferase and A/B blood group antigens in human normal and malignant endometrium in relation to morphology, age and oestrogen levels. Glycosylation Dis., 1, 153-163.
29. Raynes, J. (1982) Variations in the relative proportions of microheterogeneous forms of plasma glycoproteins in pregnancy and disease. Biomedicine, 36, 77-86.
30. 1-acid glycoprotein. Biochim. Biophys. Acta, 492, 291-301.
31. 1-acid glycoprotein: variation during the menstrual cycle in healthy women, and profile in women receiving estrogen-progestogen treatment. Clin. Chim. Acta, 187, 235-242.
32. 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by Estradiol-17β. J. Immunol., 142, 3134-3139.
33. Tilg, H., Vannier, E., Vachino, G., Dinarello, C.A. and Mier, J.W. (1993) Antiinflammatory properties of hepatic acute-phase proteins: Preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells. J. Exp. Med., 178, 1629-1636.
34. 1-acid glycoprotein (orosomucoid). Biochem. J., 289, 767-770.
35. Vandenbroucke, J.P., Valkenburg, H.A., Boersma, J.W., Cats, A., Festen, J.J.M., Huber-Bruning, O and Rasker, J.J. (1982) Oral contraceptives and rheumatoid arthritis: Further evidence for a preventive effect. Lancet, 2, 839-842.
36. Van Dijk, W., Turner, G.A. and Mackiewicz, A. (1994) Changes in glycosylation of acute-phase proteins in health and disease: occurence, regulation and function. Glycosylation Dis., 1, 5-14.
37. Van Dijk, W. and Mackiewicz, A. (1995) Interleukin-6-type cytokine-induced changes in acute-phase protein alycosylation. Ann. N.Y. Acad. Sci., 762, 319-330.
38. 1-Acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function. Glycoconjugate J., 12, 227-233.
39. 1-acid glycoprotein in acute and chronic inflammation. Glycoconjugate J., 10, 316-317.
40. 1-acid glycoprotein (orosomucoid) Glycosylation Dis., 1, 45-52.
41. 1-acid glycoprotein. Clin. Chim. Acta, 109, 59-67.
42. White, S. and Kimber, S.J. (1994) Changes in α(1-2)-fucosyltransferase activity in the murine endometrial epithelium during the estrous cycle, early pregnancy, and after ovariectomy and hormone replacement. Biol. Reprod., 50, 73-81.